LAS-

CL:CLINICALASCONDES

Clínica Las Condes

Stock

Last Close

11,114.00

20/11 13:46

Market Cap

118.10B

Beta: -

Volume Today

15

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Sep '22	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24
net income	-1.14B -	-142.67M 87.51%
depreciation and amortization	1.35B -	10.87B 704.08%
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	19.50B -	-7.67B 139.34%
net cash provided by operating activities	19.71B -	3.05B 84.50%
investments in property plant and equipment	-1.54B -	-2.93B 89.79%	-1.71B 41.48%	-1.06B 38.41%	-1.50B 42.50%	-1.33B 11.87%	-438.18M 66.94%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites	-3.63B -	11.20B 408.38%
net cash used for investing activites	-5.17B -	7.74B 249.59%	-1.71B 122.14%	-1.06B 38.41%	-1.50B 42.50%	-1.33B 11.87%	-438.18M 66.94%	734.68M 267.67%
debt repayment	-20.45B -	-8.31B 59.36%	-5.54B 33.36%	-5.52B 0.36%	-5.65B 2.36%	-235M 95.84%	-6.76B 2,774.62%	-612.91M 90.93%
common stock issued
common stock repurchased
dividends paid			-1.78B -	-567.94M 68.13%
other financing activites	5.08B -	-1.33B 126.13%
net cash used provided by financing activities	-15.37B -	-9.64B 37.27%	-8.25B 14.37%	-6.04B 26.88%	-7.02B 16.24%	-1.39B 80.16%	-7.93B 469.37%	-554.34M 93.01%
effect of forex changes on cash
net change in cash	-835.19M -	1.15B 237.95%	-1.02B 188.88%	-3.16B 208.24%	-6.18B 95.80%	-4.35B 29.68%	-575.95M 86.75%	-2.32B 303.17%
cash at beginning of period	19.57B -	18.74B 4.27%	19.89B 6.15%	18.87B 5.15%	15.71B 16.73%	9.53B 39.34%	5.18B 45.61%	4.61B 11.11%
cash at end of period	18.74B -	19.89B 6.15%	18.87B 5.15%	15.71B 16.73%	9.53B 39.34%	5.18B 45.61%	4.61B 11.11%	2.28B 50.41%
operating cash flow	19.71B -	3.05B 84.50%
capital expenditure	-1.54B -	-2.93B 89.79%	-1.71B 41.48%	-1.06B 38.41%	-1.50B 42.50%	-1.33B 11.87%	-438.18M 66.94%
free cash flow	18.16B -	125.72M 99.31%	-1.71B 1,462.98%	-1.06B 38.41%	-1.50B 42.50%	-1.33B 11.87%	-438.18M 66.94%

All numbers in (except ratios and percentages)